2016
Gli promotes epithelial-mesenchymal transition in human lung adenocarcinomas
Li H, Yue D, Jin JQ, Woodard GA, Tolani B, Luh TM, Giroux-Leprieur E, Mo M, Chen Z, Che J, Zhang Z, Zhou Y, Wang L, Hao X, Jablons D, Wang C, He B. Gli promotes epithelial-mesenchymal transition in human lung adenocarcinomas. Oncotarget 2016, 5: 80415-80425. PMID: 27533453, PMCID: PMC5348330, DOI: 10.18632/oncotarget.11246.Peer-Reviewed Original ResearchMeSH KeywordsA549 CellsAdenocarcinomaAdenocarcinoma of LungAnimalsAntigens, CDAntineoplastic AgentsCadherinsCell MovementEpithelial-Mesenchymal TransitionFemaleGene Expression Regulation, NeoplasticHedgehog ProteinsHumansLung NeoplasmsMaleMice, NudeMiddle AgedNeoplasm InvasivenessSignal TransductionSmoothened ReceptorTime FactorsTumor BurdenXenograft Model Antitumor AssaysZinc Finger Protein GLI1ConceptsEpithelial-mesenchymal transitionLung adenocarcinomaE-cadherin expressionTumor growthLung adenocarcinoma metastasisPotential therapeutic targetInhibition of GLICell migrationAdenocarcinoma metastasisLung cancerInvasion/metastasisTumor invasion/metastasisIndependent cohortGLI inhibitorsSmall molecule inhibitorsTherapeutic targetAdenocarcinomaHuman lungTherapeutic agentsMetastasisCell invasionWound healingCommon typeRole of GliMolecule inhibitors
2015
Lung Cancer Stem Cells
Woodard G, Jablons D. Lung Cancer Stem Cells. 2015, 199-225. DOI: 10.1007/978-3-319-21030-8_8.Peer-Reviewed Original ResearchLung cancer stem cellsCancer stem cellsLung cancerTherapeutic targetSmall cell lung cancerStem cellsCancer stem cell markersSquamous cell cancerCell lung cancerMultiple new drugsPromising therapeutic targetImportant therapeutic targetCell of originCancer stem cell hypothesisStem cell markersTumor resurgenceRecurrent diseaseCell cancerCancer mortalityClinical trialsNovel therapiesNew therapiesHigh proliferative capacitySmall molecule inhibitorsStem cell hypothesis